Crinetics Pharmaceuticals
CRNX
$26.81
Share price
-7.14%
Change (1 day)
-43.70%
Change (1 year)
Categories
Crinetics Pharmaceuticals (CRNX) - Cash on Hand
Cash on Hand as of December 2024 : $1.35 Billion USD
According to Crinetics Pharmaceuticals's latest financial reports the company has $1.35 Billion USD in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Crinetics Pharmaceuticals - Cash on Hand chart (from 2017 to 2024)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2024-12-31 | $1.35 B | 142.42% |
| 2023-12-31 | $0.55 B | 67.02% |
| 2022-12-31 | $0.33 B | 0.22% |
| 2021-12-31 | $0.33 B | 95.29% |
| 2020-12-31 | $0.17 B | 44.33% |
| 2019-12-31 | $0.11 B | -27.75% |
| 2018-12-31 | $0.16 B | 1054.7% |
| 2017-12-31 | $14.19 M | 16.79% |
| 2016-12-31 | $12.15 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 | $0.25 B | -81.10% | 🇺🇸 USA |